Subscribers’ Weekly 08 Aug 2025
08 Aug 2025
ALL MARKETS
US$ 225.00
Performance Benchmark
Australia/New Zealand
Funds
China
Investments
+ Show All
Japan/South Korea
Funds
Investments
+ Show All
Rest of Asia/Rest of the World
Funds
All Markets Audio
Related Publications
OrbiMed Advisors LLC and Qiming Venture Partners have co-led the US$131 m pre-IPO round of Minghui Pharmaceutical ......
Listen to Australia/New Zealand Investments (Subscribers' Weekly 08 Aug 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.